BALB/c mice were administered (i.p.) once the indicated mAbs (150 μg/mouse in 0.5 mL 0.9% NaCl) or 0.5 mL 0.9% NaCl, and 2 h later, the mice received a lethal dose of C. albicans (5 × 106 CFU/mouse). The survival rate of mice treated with mAb 5H5 was significantly higher than that of mice injected with 0.9% NaCl or an irrelevant mAb; #p < 0.05. The survival time of mice passively immunized with mAb 3G11 or mAb 5H5 was significantly higher than that of mice administered with 0.9% NaCl or an irrelevant mAb; *p < 0.01, **p < 0.001.</p
<p>Mice were administered mAb(s) by the i.p. route followed 18 h later by i.n. challenge with 15 LD<...
<p>MAb protection activity was determined using the mouse protection assay with 5 estimated MLD<sub>...
<p>Mice having received a single oral vaccination with strains V674pF1 or V674 at the indicated dose...
<p>(<b>a</b>) Survival of mice after intraperitoneal infection with 5.10<sup>7</sup> CfUs of <i>C. a...
<p>Balb/c mice (n = 20 per arm) were vaccinated with rHyr1p-N mixed with alum or alum alone (control...
<p>A – Protection afforded by passive immunization. Mice (n = 8–10 mice/group) were treated with the...
<p>(A) Survival of vaccinated or control mice (n = 15 per group) infected intravenously with <i>C. a...
<p>mAbs were administered by the i.p. route at the doses (µg) listed. Intranasal challenge was perfo...
<p>The human and mouse anti-F1 and anti-V mAbs were given i.p. to mice 24 hrs before parenteral chal...
<p>Two-day-old suckling mice (ICR strain) were injected intracranially (i.c.) with 1×10<sup>4</sup> ...
<p>Percent survival of infected mice was evaluated according to Mantel-Cox Log rank test and the dif...
<p>Ten mice in each group were treated intraperitoneally with 200 µg of purified MAb m61 or ch61 24 ...
<p>(A) The Kaplan-Meier survival curve. BALB/c mice (n=7 per group in two separate experiments) were...
<p>BoNT/A (10 LD50) was administered via intra-peritoneal injection to Swiss ...
<p>A. Prophylactic administration of 514G3 protects mice against lethal challenge with MRSA in a bac...
<p>Mice were administered mAb(s) by the i.p. route followed 18 h later by i.n. challenge with 15 LD<...
<p>MAb protection activity was determined using the mouse protection assay with 5 estimated MLD<sub>...
<p>Mice having received a single oral vaccination with strains V674pF1 or V674 at the indicated dose...
<p>(<b>a</b>) Survival of mice after intraperitoneal infection with 5.10<sup>7</sup> CfUs of <i>C. a...
<p>Balb/c mice (n = 20 per arm) were vaccinated with rHyr1p-N mixed with alum or alum alone (control...
<p>A – Protection afforded by passive immunization. Mice (n = 8–10 mice/group) were treated with the...
<p>(A) Survival of vaccinated or control mice (n = 15 per group) infected intravenously with <i>C. a...
<p>mAbs were administered by the i.p. route at the doses (µg) listed. Intranasal challenge was perfo...
<p>The human and mouse anti-F1 and anti-V mAbs were given i.p. to mice 24 hrs before parenteral chal...
<p>Two-day-old suckling mice (ICR strain) were injected intracranially (i.c.) with 1×10<sup>4</sup> ...
<p>Percent survival of infected mice was evaluated according to Mantel-Cox Log rank test and the dif...
<p>Ten mice in each group were treated intraperitoneally with 200 µg of purified MAb m61 or ch61 24 ...
<p>(A) The Kaplan-Meier survival curve. BALB/c mice (n=7 per group in two separate experiments) were...
<p>BoNT/A (10 LD50) was administered via intra-peritoneal injection to Swiss ...
<p>A. Prophylactic administration of 514G3 protects mice against lethal challenge with MRSA in a bac...
<p>Mice were administered mAb(s) by the i.p. route followed 18 h later by i.n. challenge with 15 LD<...
<p>MAb protection activity was determined using the mouse protection assay with 5 estimated MLD<sub>...
<p>Mice having received a single oral vaccination with strains V674pF1 or V674 at the indicated dose...